HCW Biologics (HCWB) Total Liabilities (2020 - 2025)
HCW Biologics' (HCWB) quarterly Total Liabilities came in at $21.8 million in Q4 2025, down 41.21% YoY from $37.0 million in Q4 2024, and down 21.04% on a QoQ basis from $27.6 million in Q3 2025.
HCW Biologics (HCWB) Total Liabilities (2020 - 2025) Analysis & Trends
HCW Biologics (HCWB) has 6 years of Total Liabilities data on file, last reported at $21.8 million in Q4 2025.
- Quarterly Total Liabilities fell 41.21% year-over-year to $21.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.8 million (down 41.21% YoY) and the FY2025 annual result came in at $21.8 million, down 41.21% from the prior year.
- Total Liabilities retreated to $21.8 million in Q4 2025, from $27.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $56.4 million in Q3 2021 to a low of $1.2 million in Q2 2022.
- A 5-year average of $20.1 million and a median of $15.1 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities tumbled 90.46% — and 2023, when it surged 776.72%.
- Tracing HCWB's Total Liabilities over 5 years: stood at $2.3 million in 2021, then jumped by 304.06% to $9.4 million in 2022, then surged by 60.46% to $15.1 million in 2023, then surged by 145.86% to $37.0 million in 2024, then tumbled by 41.21% to $21.8 million in 2025.
- The last three Total Liabilities figures came in at $21.8 million (Q4 2025), $27.6 million (Q3 2025), and $29.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | HCW Biologics | 2.86 Mn | 2.11 Mn | -93,887.00 | 19.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.76 Mn |
| Sep 30, 2025 | 27.55 Mn |
| Jun 30, 2025 | 28.96 Mn |
| Mar 31, 2025 | 34.85 Mn |
| Dec 31, 2024 | 37.01 Mn |
| Sep 30, 2024 | 36.53 Mn |
| Jun 30, 2024 | 33.12 Mn |
| Mar 31, 2024 | 21.69 Mn |
| Dec 31, 2023 | 15.05 Mn |
| Sep 30, 2023 | 11.75 Mn |
| Jun 30, 2023 | 10.90 Mn |
| Mar 31, 2023 | 10.92 Mn |
| Dec 31, 2022 | 9.38 Mn |
| Sep 30, 2022 | 8.80 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 2.32 Mn |
| Sep 30, 2021 | 56.41 Mn |
| Jun 30, 2021 | 13.03 Mn |
| Dec 31, 2020 | 15.40 Mn |